drugset / Trial / NCT03485482

Pharmacokinetic Drug-Drug Interaction Between Bisoprolol and Ivabradine in Healthy Volunteers

NCT03485482

Phase 3 Completed 18 enrolled Ain Shams University
RandomizedCrossoverOpen-labelOther

Summary

The purpose of the study was to investigate the potential interaction between ivabradine and bisoprolol in healthy subjects.

Timeline

Start
2018-03-01
Primary completion
2018-03-23
Completion
2018-03-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Bisoprolol Other / unclassified 5 mg Oral
Subject Ivabradine Small molecule 10 mg Oral